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Purpose: To study the effects of varying lipid concentrations, lipid and oil ratio, and the addi-
tion of propylene glycol and lecithin on the long-term physical stability of nanostructured lipid 
nanocarriers (NLC), skin hydration, and transepidermal water loss.
Methods: The various NLC formulations (A1–A5) were prepared and their particle size, zeta 
potential, viscosity, and stability were analyzed. The formulations were applied on the forearms 
of the 20 female volunteers (one forearm of each volunteer was left untreated as a control). The 
subjects stayed for 30 minutes in a conditioned room with their forearms uncovered to let the skin 
adapt to the temperature (22°C ± 2°C) and humidity (50% ± 2%) of the room. Skin hydration and 
skin occlusion were recorded at day one (before treatment) and day seven (after treatment). Three 
measurements for skin hydration and skin occlusion were performed in each testing area.
Results: NLC formulations with the highest lipid concentration, highest solid lipid concentra-
tion, and additional propylene glycol (formulations A1, A2, and A5) showed higher physical 
stability than other formulations. The addition of propylene glycol into an NLC system helped 
to reduce the particle size of the NLC and enhanced its long-term physical stability. All the 
NLC formulations were found to significantly increase skin hydration compared to the untreated 
controls within 7 days. All NLC formulations exhibited occlusive properties as they reduced 
the transepidermal water loss within 7 days. This effect was more pronounced with the addi-
tion of propylene glycol or lecithin into an NLC formulation, whereby at least 60% reduction 
in transepidermal water loss was observed.
Conclusion: NLCs with high lipid content, solid lipid content, phospholipid, and lecithin are 
a highly effective cosmetic delivery system for cosmetic topical applications that are designed 
to boost skin hydration.
Keywords: nanostructured lipid carriers, transepidermal water loss, skin hydration, particle 
size
Introduction
The stratum corneum consists of corneocytes filled with keratin and embedded in a 
lipid matrix. Regulation of the penetration of a topically applied product and hydra-
tion across the stratum corneum depends on this lipid rich matrix.1–3 Lipids mainly 
found in the stratum corneum are phospholipids, cholesterol-3-sulphate, cholesterol, 
ceramides, sterol esters, and free fatty acids. Sebaceous lipids found in the stratum 
corneum consist of triglycerides, wax esters, and squalene. The organized structure 
of lipids is related to the barrier properties of the skin.4,5
The skin is a viscoelastic organ.6,7 Elastic components are made of collagen and 
elastic fibers; viscous parts are formed based on friction between cells and collagen 
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bundles and other components of the dermal matrix.8 The 
stratum corneum normally maintains a 10%–20% hydration 
state.9 Water and lipid content strongly influences the fric-
tional resistance of the skin.10 Perturbation of water content in 
the skin might cause functional defect and clinical symptoms. 
Therefore, skin hydration and occlusion are of primary inter-
est in the cosmetic and dermatology fields.
Transepidermal water loss is a good indicator of impaired 
barrier function of the stratum corneum. An increase in 
transepidermal water loss indicates a disruption of the stratum 
corneum and loss of intercellular lipids. Skin hydration is 
measured by capacitance or conductance and demonstrates 
acute, chronic, narrow, or wide oscillations in a variety of skin 
conditions.11 Skin that is properly hydrated has been known 
to age more slowly than moisture-deprived skin and is better 
protected against environmental influences. An increase in 
skin hydration and lipid content helps to improve viscous 
resistance against deformation.12
Most topical preparations have an undesirable esthetic 
appearance and feel which is unacceptable to consumers 
(eg, petrolatum); therefore, the demand for novel occlusive 
agents or lipids is rising. Nanostructured lipid carriers 
(NLCs) consist of a solid lipid matrix with a certain amount 
of liquid lipid, and were introduced as a novel delivery 
system for various cosmetic active ingredients and phar-
maceutical drugs.13 They have great appeal in the cosmetic 
field as they are able to enhance the chemical stability of 
actives, provide occlusive effect to the skin and therefore 
increase skin hydration, enhance the skin bioavailability 
of actives, and increase the physical stability of topical 
formulations.14
NLCs could provide better skin hydration and occlusion 
compared to traditional delivery systems (eg, macroemulsion) 
due to its ultrafine size. NLCs localized on the skin leads 
to a formation of film. This film has an occlusive action 
to prevent water loss from the skin through  evaporation. 
The degree of occlusion skin, is based on the size of the 
 particles. The smaller the size of the particles, the less 
water that evaporates from the skin whereas the bigger 
the size of the particles, the more water that evaporates 
from the skin.14
Occlusion and skin hydration are influenced by the 
delivery system or vehicle and the ingredients used in a 
formulation. Limited studies related to the effect of the NLC 
delivery system on skin hydration and occlusion have been 
published. No study was found that explains the effect of 
various ingredients incorporated in the formulation on skin 
hydration and occlusion.
Material and methods
Materials
Span™ 40 (sorbitan monopalmitate) and Tween® 80 
(polysorbate 80) were obtained from Croda International 
(Goole, United Kingdom). Isopropyl palmitate was pur-
chased from InterMed Sdn Bhd (Kuala Lumpur, Malaysia). 
Lipocire™ DM (hydrogenated palm kernel glycerides) was 
purchased from Gattefosse (Lyon, France). Concentrated palm 
phytonutrients (major components are tocols and carotenoids) 
were obtained from the Malaysian Palm Oil Board (Kuala 
 Lumpur, Malaysia). Propylene glycol and Phospholipon® 85 G 
(soy  lecithin enriched with 85% phosphatidylcholine) was 
purchased from Lipoid GmbH (Ludwigshafen, Germany).
Preparation of nanostructured lipid 
carrier (NLC)
Melted lipid phase containing solid lipid (hydrogenated 
palm kernel glycerides), liquid lipid (isopropyl palmitate), 
3.00% lipophilic surfactant (Span 40) and 0.40% bioactive 
compounds (palm-based phytonutrients concentrates) were 
added to hot aqueous solution containing 3.00% hydrophilic 
surfactant (Tween 80). Both phases (lipid and water phases) 
were heated to 70°C. The mixture was homogenized by 
Polytron® PT 3100 homogenizer (Kinematica AG, Luzern, 
Switzerland) at 10,000 rpm for 2 minutes. The macroemul-
sion formed was cooled in an ice bath to room temperature 
(25°C). The pre-emulsion was further homogenized at 85°C 
using a high pressure homogenizer for three cycles at 750 
bars. The lipid dispersion was then cooled in an ice bath 
to room temperature (25°C).15 Compositions of the NLC 
formulations are shown in Table 1.
Table 1 Compositions of the nanostructured lipid carrier 
formulations
Ingredient Formulation (%, weight/weight)
A1 A2 A3 A4 A5
Span™ 40 3.00 3.00 3.00 3.00 3.00
Tween® 80 3.00 3.00 3.00 3.00 3.00
Lipocire™ DM 17.64 26.64 9.80 17.64 17.64
IPP 1.96 2.96 9.80 1.96 1.96
CPP 0.40 0.40 0.40 0.40 0.40
Phenonip® 0.70 0.70 0.70 0.70 0.70
Lecithin – – – 1 –
Propylene glycol – – – – 2.00
Water qs 100 qs 100 qs 100 qs 100 qs 100
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid 
lipid/liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; 
A3, nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio 
of 50:50; A4, nanostructured lipid carrier with lecithin added; A5, nanostructured 
lipid carrier with propylene glycol added; CPP, concentrated palm phytonutrients; 
IPP, isopropyl palmitate; qs, quantum satis.
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Particle size analysis
Particle size analysis for NLC was performed using photon 
correlation spectroscopy with a high performance particle 
sizer (HPP5001; Malvern Instruments Ltd, Malvern, United 
Kingdom). In photon correlation spectroscopy, the intensity 
fluctuations of scattered light arising from Brownian motion 
are measured. The size distribution of the particles was mea-
sured by the Stokes–Einstein equation. The mean particle 
size was obtained from the average of five measurements 
(ten 30-second runs) at an angle of 90 degrees. The volume 
of the sample required was 10 mm. All samples were diluted 
in distilled water to weak opalescence. The dispersant (water) 
had a refractive index of 1.333 and viscosity of 0.8905 cP 
at 25°C.
Zeta potential analysis
Zeta potential reflects the electric charge on the particle 
 surface and physical stability of colloidal systems.16 This can 
be determined by the electrophoretic mobility of particles and 
colloids dispersed in a liquid. The zeta potential  analysis was 
performed using a Zetasizer® Nano Z (ZEN 2600; Malvern 
Instruments) with five measurements (ten runs). The samples 
were diluted with distilled water and added into the equipment 
chamber. Particles with a large negative or positive zeta 
potential (more negative than −30 mV or more positive 
than +30 mV) will repel each other and will not aggregate.17
Rheological measurements
The viscosity of samples at 10 s−1 was recorded. Oscillatory 
stress sweep analysis was carried out between 0.1–100.0 Pa 
using a Physica MCR 300 rheometer (Anton Paar GmbH, 
Graz, Austria). The geometry of the cone-and-plate used in 
this test was CP 50-1.18 Dynamic oscillation testing is used 
to investigate the microscopic structures of viscoelastic 
materials, which provides information on the viscosity and 
elastic properties of the investigated delivery systems.19 In 
the stress sweep test, the oscillation frequency was fixed at 
1 Hz in order to obtain a linear viscoelastic (LVE) region. 
The region where G′ (the storage modulus) is independent 
of applied shear stress up to the critical strain value (γ
c
) is 
known as the LVE region.20
Accelerated stability testing
The stability of the NLCs was investigated by subjecting the 
formulation at room temperature (25°C), 45°C, and 5°C for 
3 months. The NLCs were also centrifuged at 3500 rpm for 
15 minutes. Three freeze–thaw cycles (one cycle = first day 
at 5°C and second day at 25°C) were performed to investigate 
the stability of the NLCs. The phase separation of NLCs was 
observed under polarized light.15
Efficacy testing (skin hydration  
and transepidermal water loss)
Twenty Asian female volunteers with healthy skin par-
ticipated in this study. All the volunteers were older than 
40 years. All the volunteers participating in the study gave 
their informed written consent. The protocol, informed con-
sent agreement, and any protocol amendments were reviewed 
and approved by an institutional review board. Each volunteer 
was instructed not to wash or use any other product on her 
forearm for at least 5 hours before the test. The evaluation was 
carried out on the forearm, in an area of 4 cm². Two areas of 
4 cm² were marked on the forearm: one was treated with the 
product while the other was kept untreated as a control. The 
formulations were applied on the forearms of the volunteers. 
The subjects stayed for 30 minutes in a conditioned room 
with their forearms uncovered to let the skin adapt to the 
temperature (22°C ± 2°C) and humidity (50% ± 2%) of the 
room. Skin hydration and skin occlusion were recorded at 
day one (before treatment) and day seven (after treatment). 
Three measurements for skin hydration and skin occlusion 
were performed in each testing area.
The effect of the samples on the skin hydration was evalu-
ated using a Corneometer® CM 825 (Courage + Khazaka 
Electronic GmbH, Cologne, Germany). The measuring 
principle of the instrument is based on the capacitance mea-
surement of a dielectric medium. The dielectric constant 
of the skin changes with the water content. The changes in 
water content of the stratum corneum are converted to arbi-
trary units of hydration. Transepidermal water loss from the 
skin was investigated using Tewameter®™ 300 (Courage + 
Khazaka). The principle of this test is based on the diffusion 
principle in an open chamber. The results are given in arbi-
trary units and expressed as an average percentage change of 
skin hydration and skin occlusion due to the application of a 
sample at each measurement point.12 All data are expressed 
as mean ± standard deviation and were statistically analyzed 
by one-way analysis of variance. Differences between the 
samples and the untreated control group were evaluated by 
Tukey’s t-test. P , 0.05 was considered significant.
Results and discussion
Particle size analysis
To investigate the influence of lipid concentration, NLCs 
(formulation A1 and A2) composed of 20% and 30% lipid 
phase (solid lipid/liquid lipid ratio of 90:10) were prepared. 
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Figure 1 Particle size of the nanostructured lipid carrier formulations during 
3-month storage.
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid 
lipid/liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; 
A3, nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 
50:50; A4, nanostructured lipid carrier with lecithin added; A5, nanostructured lipid 
carrier with propylene glycol added; NLC, nanostructured lipid carrier.
Particle size of formulation A2 had a slightly bigger particle 
size (218.60 ± 5.76 nm) when compared to formulation 
A1 (193.00 ± 1.33 nm) (Figure 1). The homogenization 
energy exerted for both NLCs was the same, but mass of 
disperse phase was increased from 20% to 30%; therefore, 
less dispersion energy was available per unit lipid leading 
to bigger particle size. This result is in agreement with the 
findings of Teeranachaideekul et al and Phipps in which the 
higher the lipid content, the higher the mean particle size 
obtained.21,22
Particle size of formulation A1 remained almost 
unchanged for 3 months, indicating that A1 was stable at 
room temperature within the tested time (Figure 1). Particle 
size for A2 increased from the first (219.60 ± 5.76 nm) to the 
third month (273.40 ± 3.92 nm) (Figure 1). This finding is 
in agreement with the findings from Seetapan et al in which 
NLCs with high lipid concentration were physically less 
stable compared to NLCs with low lipid concentration due 
to their ability to more easily recrystallize.23
The physical stability of the NLC with high solid lipid 
content (solid lipid/liquid lipid ratio of 90:10; formulation 
A1) was higher when compared to the NLC with low solid 
lipid content (solid lipid/liquid lipid ratio of 50:50; formu-
lation A3). The particle size of formulation A1 remained 
almost unchanged in 3 months, whereas the particle size 
of A3 increased 19% from the first to the second month 
 (Figure 1). This could be due to the presence of large 
quantities of solid lipid, which reduced the coalescence of 
droplets.24
The NLC with lecithin (formulation A4) showed bigger 
particle size (225.40 ± 1.84 nm) compared to the NLC with-
out lecithin (formulation A1; 193 ± 1.33 nm) and exhibited 
lower physical stability as its particle size increased from the 
first month to the third month (Figure 1). This could be due to 
the emulsification process which could produce an unstable 
system consisting of micelles and lamellar aggregates in the 
presence of lecithin. This kind of system suffers a dynamic 
process of lecithin exchange between the particles, which 
leads to phase separation and structural modification.25
The particle size of the NLC with propylene glycol (for-
mulation A5; 188.40 ± 2.72 nm) was slightly smaller when 
compared to the NLC without propylene glycol (formulation 
A1; 193 ± 1.33 nm) (Figure 1). Formulation A5 was physi-
cally stable as its particle size remained unchanged from the 
first to the third month (Figure 1). This result is in agreement 
with the findings from Chanana and Sheth in which the 
addition of propylene glycol in an emulsion system helps to 
reduce particle size and enhance physical stability.26 They 
found that propylene glycol was more effective in reduc-
ing the particle size of an emulsion compared to glycerol. 
Addition of polyhydric alcohol to an emulsion was found to 
increase the viscosity of the emulsion, which thus enhanced 
the physical stability of the emulsion.
Zeta potential analysis
Zeta potential was used to measure the particle charge and 
electrostatic repulsion. It is the potential at the surface of 
shear and it is measured in millivolts. Zeta potential is usually 
used to determine the stability of emulsion system.  According 
to the Derjaguin–Landau–Verwey–Overbeek theory,16 a sys-
tem could be classified as stable if the electrostatic repulsion 
dominated the attractive Van der Waals forces. Particles with 
zeta potentials more positive than +30 mV and more negative 
than −30 mV are normally considered stable.27 If the particles 
have a large negative or positive zeta potential, they will repel 
each other and thus are more stable.
The zeta potentials of A1, A2, A3, A4, and A5 ranged 
from −31 mV to −36 mV, suggesting acceptable electrostatic 
stability of the NLC formulations (Table 2). The results did 
not correlate with the results obtained from particle size 
analysis, stress sweep test, and accelerated stability testing. 
The zeta potential results showed that formulations A3 and 
A4 were physically stable, whereas the results of particle 
size, accelerated stability testing, and stress sweep showed 
that formulations A3 and A4 were the most unstable when 
compared with other formulations. These observations are 
in agreement with the findings of Lippacher et al in which 
the results obtained from rheological, morphological, and 
differential scanning calorimetry analyses did not correlate 
with zeta potential analysis in predicting the physical stability 
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of the loaded solid lipid nanoparticles.19 This could be due 
to the determination of zeta potential being carried out in a 
diluted state, whereby the interparticle interaction between 
particles is negligible. Therefore it cannot be used to explain 
the real condition of the prepared semisolid dispersions.
Rheological measurement
Viscosity
Table 2 shows that formulation A2 (40.12 ± 4.33 cP) 
had higher viscosity when compared to formulation A1 
(27.03 ± 3.60 cP). The increase in viscosity could be due to 
an increase in the volume of lipid phase from 20% to 30%. 
These findings were in agreement with the findings of Floyd, 
which suggested that viscosity was increased with increasing 
lipid concentration.28 Formulation A3 had lower viscosity 
when compared to formulation A1 due to the lower solid lipid 
content in A3 (Table 2). These results were in agreement with 
the findings of Freitas and Muller, in which increased solid 
lipid content led to an increase in viscosity accompanied by 
a lack of lattice defects within lipid particles.29
The viscosity of formulation A4 (46.66 ± 3.60 cP) 
was higher than formulation A1 (27.03 ± 3.60 cP) due to 
the presence of lecithin (Table 2). These findings were in 
agreement with the findings of Ishii et al in which the viscosity 
of soy bean oil emulsions stabilized with purified egg lecithin 
increased with increasing lecithin concentration.30 Formulation 
A5 (32.28 ± 2.74 cP) had higher viscosity when compared to 
formulation A1 (27.03 ± 3.60 cP) (Table 2). These observations 
were in agreement with the findings of Chanana and Sheth in 
which the increase in emulsion viscosity was found to be 
proportional to the amount of polyhydroxy alcohols (glycerin 
and propylene glycol) added to the formulation.26
Stress sweep test
Within the LVE region, formulations A1, A2, A4, and 
A5 showed that the value of G′ (storage modulus) was 
Table 2 Physical characteristics of nanostructured lipid carrier 
formulations
Sample Zeta potential (mV) Viscosity (cP) LVE (Pa)
A1 −32.57 ± 0.26 27.03 ± 3.60 0.32
A2 −31.15 ± 0.53 40.12 ± 4.33 2.00
A3 −33.17 ± 10.18 ± 0.11 –
A4 −35.57 ± 46.66 ± 3.60 0.21
A5 −31.23 ± 32.28 ± 2.74 0.51
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid 
lipid/liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; 
A3, nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 
50:50; A4, nanostructured lipid carrier with lecithin added; A5, nanostructured lipid 
carrier with propylene glycol added; LVE, linear viscoelastic region.
higher than G′′ (loss modulus), which indicates that the 
systems showed more elastic behavior than viscous behavior 
 (Figure 2). Loss modulus was higher than storage modulus for 
formulation A3, which indicates that the viscous properties 
dominated the elastic properties.31 As the liquid oil content 
increased, the elastic properties were reduced and viscous 
properties were enhanced. These results indicate that an 
increase in liquid oil content in the formulation reduces elas-
tic properties but enhances viscous properties. Table 2 shows 
that formulation A2 had a wider LVE region (2.00 Pa) when 
compared to A1 (0.32 Pa).
Test samples with high stability have a wide LVE region, 
whereas test samples with a weak and sensitive structure have 
a narrow LVE region. As the volume of lipid increased from 
20% to 30%, the width of the LVE region increased. This 
result is in agreement with the findings from Lippacher et al 
in which the increasing concentration of lipid leads to an 
increase in the particle–particle interactions and results in 
a more rigid structure.19 Formulations A3 and A4 had a 
narrower LVE region when compared to formulations A1, 
A2, and A5 (Table 2). This indicates that A3 and A4 broke 
down more easily with vibrations and small movements, and 
therefore A1, A2, and A5 were predicted to have a longer 
shelf life than A3 and A4. This result is in agreement with 
the result of accelerated stability testing, which found that 
formulations A3 and A4 were less stable when compared to 
formulations A1, A2, and A5.
Accelerated stability testing
The accelerated stability test is important for a cosmetic product 
to ensure its intended efficacy, physical, chemical, and micro-
biological quality is maintained over a period of time under 
certain conditions. A long-term stability study of a cosmetic 
product under “real life” conditions (room temperature 25°C) 
is time consuming and labor intensive. Therefore, accelerated 
stability testing is an alternative for normal long-term stabil-
ity studies, and can be carried out by subjecting a cosmetic 
product under elevated conditions over a period of time and 
observing the changes in physical appearance. The capabil-
ity of cosmetic products to remain stable for 3–4 months of 
elevated temperature and three to four freeze–thaw cycles is 
considered as having an adequate shelf life.32
Formulations A1, A2, and A5 remained stable (no phase 
separation) under centrifugation condition, three freeze–thaw 
cycles, and 3-month storage at 25°C and 45°C. Formulation 
A4 was found to separate into two layers in the first month 
at 45°C, whereas formulation A3 separated in the second 
month. These observations are in agreement with the particle 
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Figure 2 Stress sweep curve of the nanostructured lipid carrier formulations (A) A1, (B) A2, (C) A3, (D) A4, and (E) A5.
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; A3, nanostructured 
lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 50:50; A4, nanostructured lipid carrier with lecithin added; A5, nanostructured lipid carrier with propylene 
glycol added.
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size study, which showed a sudden increase in particle size 
in the second and third months of storage. No gel formation 
was observed at 5°C for all the NLC formulations. Gel for-
mation is not desirable as it may promote the expulsion of 
bioactives from NLC particles.
Efficacy testing
Skin hydration
Proper labeling is crucial if the cosmetic product is ready 
to be marketed. Clinical studies need to be carried out in 
order to provide evidence to support the claims on the label. 
The aim of the study was to investigate the effect of lipid 
content and presence of humectant on skin hydration and 
skin occlusion.
Application of NLC formulations (A1, A2, A3, A4, and 
A5) for 7 days led to a highly significant increase in average 
skin hydration from day one to day seven (P , 0.001), 
whereas untreated controls remained almost unchanged (30.65 
arbitrary units on day one and 31.80 arbitrary units on day 
seven; P . 0.05) (Figure 3). The application of NLCs led to 
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an increase in skin hydration due to the presence of occlusive 
agents found in the NLCs, ie, solid lipid (hydrogenated palm 
kernel glycerides) and liquid lipid (isopropyl palmitate). 
Due to the formation of an occlusive film on the skin, water 
evaporation from the skin was reduced for the area treated with 
NLCs. This result is in agreement with the finding by Pardeike 
and Muller in which NLC-containing cream increased the skin 
hydration more pronouncedly when compared to conventional 
cream and untreated controls.33
The NLC with 30% lipids (formulation A2) increased 
skin hydration more effectively when compared to the NLC 
with 20% lipids (formulation A1) (Figure 3). This indicates 
that skin hydration was further enhanced by the high con-
centration of lipids. Wissing and Muller reported that skin 
occlusion is dependent on the sample volume, particle size, 
and the crystallinity of lipids.34 The occlusive agent found 
in NLCs (high concentration of lipid) was responsible for 
retaining moisture in the stratum corneum. This result is in 
agreement with the findings of Souto et al.35
After the 7-day application of the NLC containing lecithin 
(formulation A4) on the skin, the increase in skin hydration 
was comparable to the NLC without lecithin (formulation 
A1). Percentage increase in skin hydration was 49.09% and 
42.62% for formulations A4 and A1, respectively (Figure 4). 
Treatment with formulation A4 increased skin hydration 
slightly higher than formulation A1, which could be due to 
the addition of occlusive agent (lecithin) to the formulation. 
The NLC containing propylene glycol (formulation A5) also 
showed comparable percentage increase in skin hydration 
when compared to the NLC formulation without propylene 
glycol (formulation A1). Percentage increase in skin hydra-
tion for formulations A5 and A1 were 48.04% and 42.62%, 
respectively (Figure 4). Formulation A5 had slightly higher 
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Figure 3 Skin hydration after the application of different nanostructured lipid 
carrier formulations for 7 days.
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid 
lipid/liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; 
A3, nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 
50:50; A4, nanostructured lipid carrier with lecithin added; A5, nanostructured lipid 
carrier with propylene glycol added; Arb, arbitrary; NLC, nanostructured lipid carrier.
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Figure 4 Percentage increase in skin hydration after the application of different 
nanostructured lipid carrier formulations for 7 days.
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid 
lipid/liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; 
A3, nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 
50:50; A4, nanostructured lipid carrier with lecithin added; A5, nanostructured lipid 
carrier with propylene glycol added; NLC, nanostructured lipid carrier.
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Figure 5 Transepidermal water loss after the application of different nanostructured 
lipid carrier formulations for 7 days.
Abbreviations: A1, nanostructured lipid carrier with 20% lipids and a solid lipid/
liquid lipid ratio of 90:10; A2, nanostructured lipid carrier with 30% lipids; A3, 
nanostructured lipid carrier with 20% lipids and a solid lipid/liquid lipid ratio of 50:50; 
A4, nanostructured lipid carrier with lecithin added; A5, nanostructured lipid carrier 
with propylene glycol added; Arb, arbitrary; NLC, nanostructured lipid carrier; 
TEWL, transepidermal water loss.
percentage increase compared to formulation A1 due to the 
presence of humectant (propylene glycol), which increased 
the hydration of the stratum corneum by drawing water from 
the dermis and air.36
Transepidermal water loss
Bioactives penetration into the stratum corneum can be 
enhanced by occlusion caused by the product, which enhances 
hydration of the stratum corneum due to the inhibition of 
water evaporation.37 Average transepidermal water loss from 
the untreated test area remained the same (8.11 arbitrary units 
on day one and 8.48 arbitrary units on day seven; P . 0.05) 
(Figure 5). Application of NLCs (formulation A1, A2, A3, 
A4, and A5) on the skin helped to reduce water loss from the 
skin when compared to the untreated control (Figure 5). This 
could be due to the small size of particles in NLCs having 
larger surface area, which give greater adhesive properties.38 
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They form a uniform compact layer on the skin surface, thus 
preventing water evaporation from the skin.39
The NLC containing 30% lipids (formulation A2) was 
slightly more effective in reducing water loss from the stra-
tum corneum compared to the NLC containing 20% lipids 
(formulation A1). Percentage reduction of transepidermal 
water loss for formulation A2 was 21.40%, whereas it was 
19.24% for formulation A1 (Figure 6). This result is in 
 agreement with the skin hydration result in which skin occlu-
sion is directly proportional to skin hydration, indicating that 
high occlusion gives high skin hydration. This result is also 
in agreement with the work done by Wissing and Muller 
in which skin occlusion is strongly dependent on the lipid 
concentration.39 This could be due to the additional lipids 
absorbed into the intercellular space of the stratum corneum 
that help to reduce transepidermal water loss.7
The NLC with high solid lipid content (90:10; formu-
lation A1) showed a much higher percentage reduction 
of water loss compared to the NLC with low solid lipid 
content (50:50; formulation A3). Percentage reduction of 
transepidermal water loss for A1 was 19.24%, whereas it was 
2.82% for formulation A3 (Figure 6). A similar finding was 
observed by Wissing and Muller in which the formulation in 
the presence of a highly crystalline lipid reduced water loss 
from the stratum corneum more effectively.39  Crystallinity 
in solid lipids was much higher than in liquid lipids, thus 
formulation A1 showed higher occlusivity compared to 
formulation A3.
The addition of lecithin into an NLC formulation effec-
tively reduced water loss from the skin when compared to 
the untreated controls (P , 0.001). Percentage of reduction 
of water loss for the NLC with lecithin (61.64%; formula-
tion A4) was much higher than the NLC without lecithin 
(19.24%; formulation A1) (Figure 6). Lecithin is an emollient 
which helps to replace the absence of natural skin lipids in 
the space between corneocytes in the stratum corneum to 
prevent transepidermal water loss.40
After the 7-day application of the NLC contain-
ing propylene glycol (formulation A5), a highly sig-
nificant difference in the reduction of transepidermal 
water loss as compared to the untreated controls was 
observed (P , 0.001). The addition of propylene glycol 
helped to reduce water loss from the skin dramatically 
when compared to the NLC without propylene glycol 
(formulation A1). Percentage reduction of transepidermal 
water loss for formulation A5 was 60.43%, whereas it was 
19.24% for formulation A1 (Figure 6). Propylene glycol 
is an odorless liquid which functions as a humectant and 
occlusive agent, and thus has the ability to form a film on 
the skin evenly and help to reduce the evaporation of water 
from the skin barrier.41
Conclusion
NLC formulations A1, A2, and A5 exhibited good physical 
stability in terms of particle size. The in vivo study showed 
that all the NLC formulations were able to significantly 
increase skin hydration in 7 days of treatment. All the NLC 
formulations reduced transepidermal water loss within 
7 days and this effect was more pronounced in NLCs with 
the addition of propylene glycol or lecithin. In conclusion, 
NLCs with the addition of propylene glycol, lecithin, high 
lipid content, and solid lipid content are promising systems 
for cosmetics, with a proven effect on skin hydration and 
transepidermal water loss.
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